Atlas Trials

Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion

Clinical trial NCT01551069 · COMPLETED

Trial details

NCT number
NCT01551069
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Start date
2012-03-01
Primary completion
2013-12-01
Enrollment
103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.